(Q45939055)

18 December 2017

title

Hyperforin is a novel type of 5-lipoxygenase inhibitor with high efficacy in vivo. (English)

1 reference

18 December 2017

12

Gisbert Schneider

1 reference

18 December 2017

13

Olof Rådmark

1 reference

18 December 2017

14

Lidia Sautebin

1 reference

18 December 2017

5

Andreas Koeberle

1 reference

18 December 2017

10

Dieter Steinhilber

1 reference

18 December 2017

15

Oliver Werz

1 reference

18 December 2017

2

Carlo Pergola

1 reference

18 December 2017

Gabriele Dodt

6

object named as

Gabriele Dodt

1 reference

18 December 2017

Christina Hoernig

8

object named as

Christina Hoernig

1 reference

18 December 2017

Marika Hoffmann

7

object named as

Marika Hoffmann

1 reference

18 December 2017

author name string

Christian Feisst

1

1 reference

18 December 2017

Marija Rakonjac

3

1 reference

18 December 2017

Antonietta Rossi

4

1 reference

18 December 2017

Lutz Fischer

9

1 reference

18 December 2017

Lutz Franke

11

1 reference

18 December 2017

publication date

5 July 2009

1 reference

18 December 2017

Cellular and Molecular Life Sciences

published in

1 reference

18 December 2017

volume

66

1 reference

18 December 2017

issue

16

1 reference

18 December 2017

page(s)

2759-2771

1 reference

18 December 2017

https://scigraph.springernature.com/pub.10.1007/s00018-009-0078-3

exact match

0 references

cites work

Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00018-009-0078-3

Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00018-009-0078-3

Induction of 5-lipoxygenase activation in polymorphonuclear leukocytes by 1-oleoyl-2-acetylglycerol

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00018-009-0078-3

Coactosin-like protein supports 5-lipoxygenase enzyme activity and up-regulates leukotriene A4 production

21 January 2018

1 reference

12 December 2020

Caspase-mediated degradation of human 5-lipoxygenase in B lymphocytic cells

1 reference

12 December 2020

ERK-mediated regulation of leukotriene biosynthesis by androgens: a molecular basis for gender differences in inflammation and asthma

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

The N-terminal "beta-barrel" domain of 5-lipoxygenase is essential for nuclear membrane translocation

1 reference

12 December 2020

The N-terminal domain of 5-lipoxygenase binds calcium and mediates calcium stimulation of enzyme activity

1 reference

12 December 2020

Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation

1 reference

12 December 2020

5-lipoxygenase inhibitory activity of zileuton

1 reference

12 December 2020

Prostaglandins and leukotrienes: advances in eicosanoid biology

1 reference

12 December 2020

Phosphorylation- and stimulus-dependent inhibition of cellular 5-lipoxygenase activity by nonredox-type inhibitors

1 reference

12 December 2020

Molecular basis of the specific subcellular localization of the C2-like domain of 5-lipoxygenase

1 reference

12 December 2020

Human 5-lipoxygenase associates with phosphatidylcholine liposomes and modulates LTA4 synthetase activity

1 reference

12 December 2020

St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor

1 reference

12 December 2020

Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase

1 reference

12 December 2020

Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities

1 reference

12 December 2020

Regulation of 5-lipoxygenase enzyme activity

1 reference

12 December 2020

Regulation of the human leukocyte 5-lipoxygenase: stimulation by micromolar Ca2+ levels and phosphatidylcholine vesicles

1 reference

12 December 2020

A test system for leukotriene synthesis inhibitors based on the in-vitro differentiation of the human leukemic cell lines HL-60 and Mono Mac 6.

1 reference

12 December 2020

Evaluation of 5-lipoxygenase inhibitors, zileuton, A-78773 and ICI-D-2138 in an ionophore (A-23187)-induced pleural inflammation model in the rat

1 reference

12 December 2020

The C2-like beta-barrel domain mediates the Ca2+-dependent resistance of 5-lipoxygenase activity against inhibition by glutathione peroxidase-1.

1 reference

12 December 2020

1-Oleoyl-2-acetylglycerol stimulates 5-lipoxygenase activity via a putative (phospho)lipid binding site within the N-terminal C2-like domain

1 reference

12 December 2020

5-Lipoxygenase: regulation of expression and enzyme activity

1 reference

12 December 2020

Molecular pharmacological profile of the nonredox-type 5-lipoxygenase inhibitor CJ-13,610.

1 reference

12 December 2020

Phorbol ester up-regulates capacities for nuclear translocation and phosphorylation of 5-lipoxygenase in Mono Mac 6 cells and human polymorphonuclear leukocytes

1 reference

12 December 2020

Hyperforin Blocks Neutrophil Activation of Matrix Metalloproteinase-9, Motility and Recruitment, and Restrains Inflammation-Triggered Angiogenesis and Lung Fibrosis

1 reference

12 December 2020

Activation of 5-lipoxygenase by cell stress is calcium independent in human polymorphonuclear leukocytes

1 reference

12 December 2020

5-Lipoxygenase interacts with coactosin-like protein

1 reference

12 December 2020

5-Lipoxygenase: Cellular Biology and Molecular Pharmacology

1 reference

12 December 2020

Suppression of receptor-mediated Ca2+ mobilization and functional leukocyte responses by hyperforin

1 reference

12 December 2020

5-Lipoxygenase knockout mice exhibit a resistance to pleurisy and lung injury caused by carrageenan

1 reference

12 December 2020

Studies on the antioxidative activity of phloroglucinol derivatives isolated from hypericum species

1 reference

12 December 2020

Therapeutic options for 5-lipoxygenase inhibitors

1 reference

12 December 2020

Nonredox 5-lipoxygenase inhibitors require glutathione peroxidase for efficient inhibition of 5-lipoxygenase activity

1 reference

12 December 2020

10.1007/S00018-009-0078-3

Identifiers

DOI

1 reference

18 December 2017

Dimensions Publication ID

1049417524

0 references

1 reference

18 December 2017